Illumina forecasts flat 2024 sales as sluggish demand drags on
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Illumina (ILMN) PT Raised to $135 at JPMorgan
February 9, 2024 10:27 AM ESTJPMorgan analyst Rachel Vatnsdal raised the price target on Illumina (NASDAQ: ILMN) to $135.00 (from $110.00) while maintaining a Neutral rating.
The analyst comments "Illumina (ILMN) reported 4Q revenues of $1.12B in line with pre-announcement (+4% y/y reported, +4% cc) and above the then-consensus of $1.07B. The quarter was driven by 79 NovaSeq X shipments (vs. guide of ~62 guided at midpoint) bringing the total installed base to 352 instruments, paired with... More
